Anti-inflammatory drug shown to reduce risk of death for hospitalized Covid-19 patients
Tocilizumab, an intravenous anti-inflammatory drug used for rheumatoid arthritis, has been shown to reduce the risk of death for patients hospitalized with severe Covid-19, as well as reducing the risk of ventilation and the amount of time until discharged from hospital.
Source: cnn.com